Magnetic Particle Imaging (MPI) is a rapidly developing imaging modality that directly measures and maps the concentration of injected superparamagnetic iron oxide nanoparticles (SPIOs). Since the agent does not cross the blood-brain barrier, cerebral SPIO concentration provides a direct probe of Cerebral Blood Volume (CBV). Here we provide an initial demonstration of the ability of MPI to detect functional CBV changes (fCBV) by monitoring SPIO concentration during hypercapnic manipulation in a rat model. As a tracer detection method, MPI offers a more direct probe of agent concentration and therefore fCBV than MRI measurements in which the agent is indirectly detected through perturbation of water relaxation time constants such as T 2 *. We found that MPI detection could measure CBV changes during hypercapnia with high CNR (CNR ¼ 50) and potentially with high temporal resolution. Although the detection process more closely resembles a tracer method, we also identify evidence of physiological noise in the MPI time-series, with higher time-series variance at higher concentration levels. Our findings suggest that CBV-based MPI can provide a detection modality for hemodynamic changes. Further investigation with tomographic imaging is needed to assess tomographic ability of the method and further study the presence of time-series fluctuations which scale with signal level similar to physiological noise in resting fMRI time-courses.
Introduction
In this work, we investigate the feasibility of Magnetic Particle Imaging (MPI) as an alternative functional neuroimaging modality to functional MRI for detection of hemodynamic modulations. While MRI is a versatile imaging method capable of measuring in vivo hemodynamic changes associated with brain activation, the CNR of fMRI remains problematically low. Low CNR can lead to low detection rates of subtle activations in task-based studies and weak or missed network connections in functional connectivity studies. In response, it is common to use group averaging to uncover population effects, which limits the utility of fMRI for individualized medicine to only the strongest activation paradigms and most robust resting-state networks.
Iron oxide nanoparticle contrast agents are widely used in preclinical/translational fMRI experiments to increase sensitivity and spatial specificity compared to endogenous contrast sources such as BOLD (Mandeville et al., 1998 (Mandeville et al., , 2004 Vanduffel et al., 2001; Leite et al., 2002; Van Camp et al., 2005) . Used as a blood-pool agent, iron oxide nanoparticles provide an indirect reporter of CBV changes through the relationship between the voxel's iron concentration (and thus blood content) and the local T 2 * relaxation rate. CBV methods have also been shown to improve CNR in human functional imaging experiments using Ferumoxytol (Qiu et al., 2012; Baumgartner et al., 2017; D'Arceuil et al., 2013) . Additionally, CBV-based fMRI has been shown to better localize brain activation (Zhao et al., 2005; Fukuda et al., 2006; Mandeville and Marota, 1999) . But, direct quantification of CBV changes during activation using SPIO facilitated MRI measurements is complicated by the simultaneous signal increases caused by the BOLD effect, which partially cancels the signal decreases induced by the CBV increase during activation (Leite et al., 2002) .
Although use of iron oxide blood-pool agents increases fractional signal changes in response to CBV changes and therefore improves CNR, there is still need for improvement. In this work, we investigate the use of Magnetic Particle Imaging (MPI) detection to track local iron concentrations and thus directly monitor functional CBV changes (fCBV) versus time. Cell tracking studies (Zheng et al., 2015) suggest that high MPI sensitivity can be achieved, and simulation studies of rodent and human imagers (Mason et al., 2017) support the potential of MPI-based functional neuroimaging, a modality we term "fMPI." Here we attempt to experimentally validate fMPI's potential by measuring time-varying in vivo MPI signals during hypercapnia modulation in rodents.
MPI is an emerging imaging modality (distinct from MRI) introduced by Gleich and Weizenecker (2005) . In MPI, the signal from injected SuperParamagnetic Iron Oxide nanoparticles (SPIOs) is directly measured and mapped to form images of SPIO concentrations. While there is no magnetic resonance effect in MPI, it shares many methodological similarities with MRI. For example, the signal source is excited with an applied AC magnetic field (the "drive field") and measured by Faraday detection using receiver coils. However, unlike MRI, the alternating magnetic response originates directly from the SPIO and is measured simultaneously with the applied drive field. Since the simultaneous drive field is orders of magnitude larger than the detected fields from the magnetized iron particles, the nonlinear magnetization curve of the SPIO is leveraged to mitigate potential signal masking by the drive field. The large oscillating drive field propels the SPIO magnetization repeatedly into the saturation regime, and this nonlinear response generates signal components at harmonics of the drive frequency. The MPI signal is derived from these harmonic components, eliminating the unwanted direct detection of flux from the drive coil. Retention of only the harmonics also ensures that MPI does not pick up linear (paramagnetic and diamagnetic) sources, enabling zero-background images. The nonlinear response also forms the basis for MPI image encoding (Buzug et al., 2012; Goodwill and Conolly, 2010 ), which will not be discussed here since it is not used in the described experiments. Thus, the nonlinear magnetization curve of the SPIO is an essential property of MPI's signal detection.
In order to perform proof-of-concept validation of the ability of MPI to detect and ultimately map fCBV changes, we analyzed the MPI detected signal during modulation of rodent CBV from a hypercapnic challenge. We used a single-sided MP drive coil and detector to monitor changes in the detected signal at harmonics of the drive frequency. Compared to fully tomographic MPI scanners (Gleich and Weizenecker, 2005; Conolly, 2010, 2012; Weizenecker et al., 2008) , the single-sided MP detector is a relatively simple coil assembly which measures the detected signal within the sensitive volume immediately under the coil. The experimental results show that the blood volume changes induced by ventilated CO 2 modulation can be readily measured with high CNR using MPI detection. We also show that the detected hemodynamic signal shows the presence of "physiological noise" presumably from hemodynamic fluctuations. This suggests that it might be possible to do the equivalent of functional connectivity analysis with fMPI time-series images. These results motivate further work toward development of a full 3D fMPI scanner.
Materials and methods

Instrument design
The two basic functions of the detector system are to 1) produce a low-distortion sinusoidal drive field to modulate the SPIO magnetization and 2) simultaneously and sensitively measure the 3rd harmonic component of the SPIO's magnetic response to the drive field. Fig. 1 shows a schematic of our instrument, which uses a National Instrument Data Acquisition System (NI USB-6363, National Instruments Corp, Austin, TX) with MATLAB (MathWorks, Natick, MA) GUI interface as the console. This console generates the sinusoidal drive field waveform and digitizes the MPI signal from the receive chain.
Since the receive chain will be detecting small magnetization responses of SPIOs at harmonics of a single ideal drive frequency, it is important to produce a low-distortion drive field that is free of harmonics. The drive chain produces an amplitude-adjustable drive field at the surface of the rodent's skull using an AE Techron 7224 power amplifier (Elkhart, IN), a high-power 4th order low-pass filter, and a drive coil (L drive ), which together with the capacitance in the filter forms a series LC circuit resonant at 25 kHz. The 4th order low-pass ladder filter provides 80 dB of attenuation between 25 kHz and 75 kHz in simulation. The schematic and frequency response are shown in Supplementary  Fig. 1 . Even with this filter, some harmonic content from nonlinearities in the drive system is picked up in the receive system. Therefore, the console adds a small adjustable harmonic signal to the digitally produced drive field waveform to cancel remaining harmonic content.
The receiver system needs to overcome two challenges. First, it must be sufficiently isolated from the drive field to substantially reduce direct pickup of this field, which can saturate the preamplifier and exceed the dynamic range of the ADC. Second, it must detect the magnetization from the SPIOs with high sensitivity. To reduce the direct drive field feedthrough, a gradiometer receiver coil configuration is used (described below). The gradiometer receive coil is tuned to 75 kHz (the third harmonic of the drive frequency) as a parallel LC circuit. Additionally, a 25 kHz notch filter is used to further reduce feedthrough of the drive Fig. 1 . Schematic of MPI single-sided detector. A National Instruments DAQ is used as console, generating a 25 kHz analog burst pulses for the drive field and digitizing the simultaneously measured MPI signal. An adjustable 75 kHz waveform is added to the 25 kHz output to cancel distortion generated in the drive chain. The drive field waveform is amplified (AE Techron 7224) and low-passed filtered before generating the AC drive field in the drive coil. The non-linear SPIO magnetization is picked-up by the nested gradiometer receiver coil, which is tuned to the 3rd harmonic (75 kHz) of the drive frequency. The front-end also includes a notch filter (to attenuates direct feedthrough of the drive field), a low-noise preamplifier (SR560), and an additional high-pass filter stage (SR650).
frequency. The resonant circuit schematic and simulated frequency response is shown in Supplementary Fig. 2 .
To achieve good sensitivity in the receive chain, a Stanford Research Systems SR560 (Sunnyvale, CA) low-noise preamplifier with 4nV/√Hz input noise is used to amplify the MPI signal. The parallel LC gradiometer provides a high impedance, which is nearly optimal for the preamplifier noise performance. With this configuration we expect most of the detected noise to come from copper losses in the gradiometer (Mason et al., 2017) . Finally, a second-stage high-pass filter SR650 (Stanford Research Systems, Sunnyvale, CA) is used to further attenuate 25 kHz feedthrough before console digitization. Note, the receive chain described here detects only the largest (third) harmonic of the MPI signal. While this simplifies the setup by allowing a tuned receive coil that reduces the filtering requirements, the signal power in the higher harmonics is not utilized. Fig. 2 shows a detailed schematic and photos of the detector coil assembly. The solenoid drive coil (Fig. 2b) has a 4.4 cm diameter, an 8.9 cm length, and consists of 145 turns of Litz wire (AWG 20 5/39/42) in 2 layers. This yields an inductance of 340 μH. Nested inside the solenoid is the 1.7 cm diameter gradiometer receiver coil (Fig. 2c) , comprised of 2 separate 1 cm long 40-turn sections wound with 24 gauge solid copper wire in opposite directions. Ideally, when the gradiometer is exactly centered in the solenoid, the voltage induced by the drive field in the gradiometer sections cancel (due to the opposing turn directions). To facilitate fine adjustment of this cancellation, a threaded rod with adjustment wheel is built into the coil assembly to adjust their relative position. Experimentally, when the gradiometer is carefully positioned, >80 dB of voltage attenuation of the drive field feedthrough is achievable.
Ohmic heating of the drive coil due to the large currents used to drive the nanoparticles requires the experiment be performed with a low duty cycle (12 ms of drive current followed by 1s of rest). The experimental sensitivity could thus be improved by adding active cooling (via water or air flow) allowing a higher measurement duty cycle. Since good inductive balance is achieved by the gradiometer arrangement, relatively little current flows in the receiver circuit, but it experiences some heating through proximity to the drive coil.
Detector sensitivity profilei
Unlike a full MPI scanner, the single-sided detector does not use a selection field for image encoding. Instead, we rely only on the localized sensitivity profile of the detector for signal localization. Fig. 3 shows the simulated sensitivity profile under the surface of the coil assembly overlaid on an anatomical reference of a rat's head (Goto et al., 2010) . The map was generated by simulating the acquired 3rd harmonic signal from point sources of SPIO particles in a 3D grid using an ideal Langevin model (L(x) ¼ coth(x) À1/x). Although the detector is actually most sensitive directly under the surface (in the scalp), taking a sensitivity-weighted sum of the voxels in the brain reveals that approximately 24% of the brain is detected by the system. Assuming a brain volume of 1200 mm 3 (10.6 mm cube), 24% is equivalent to 288 mm 3 (6.5 mm cube).
Acquisition parameters
The drive field amplitude can be varied, but is typically operated to produce a 10-15 mT field at the surface of the drive coil. For these experiments, a 25 kHz sinusoidal drive field was produced in 16 ms bursts every second, during which the pre-amplified (voltage gain ¼ 500) . Simulated sensitivity map under surface of the single-sided detector overlaid on a T1-weighted MRI image of a rat head. The sensitivity map was produced by simulating the acquired the 3rd harmonic signal for discrete SPIO samples at each location. The volume of the brain weighted by the sensitivity profile of the detector is about 24% percent of the full brain volume.
gradiometer voltage was concurrently sampled by the ADC at a 500 kS/s rate with a range of AE0.1 V. The initial 4 ms of the acquired data is removed to eliminate transient artifacts, and the 75 kHz component is extracted from the Discrete Fourier Transform (DFT) of the remaining 12 ms of data. Thus, each drive-field burst results in a single recorded point every second, and together these form the measured MPI timeseries. Before the SPIO injection, the system is run for about 1 h to warm up. During this warm-up period, there is a small 75 kHz signal component that drifts with thermal changes in the system and eventually stabilizes. Before beginning an experiment, the digital 75 kHz cancellation waveform generated as part of the drive-field waveform is adjusted in amplitude and phase to cancel this unwanted component to <200 nV.
Phantom sensitivity experiment
To evaluate the sensitivity of the system, phantom experiments were conducted using PEG Carboxyl Iron Oxide Nanoparticles with a 25 nm core (SPP-25-25, Ocean Nanotech, San Diego, CA, USA). Three 18 μL bulbs were filled with different SPIO concentrations in water, containing 4.5 μg, 450 ng, and 45 ng of Fe. During a continuous time-series data set (no averaging), each sample bulb phantom was positioned at various distances from the end of the detector, d ¼ [10 mm, 8 mm, 6 mm, 4 mm, 2 mm, 0 mm] (Fig. 4) . Data collection began with the phantom positioned 10 cm from detector (outside detectable region). The position was alternated between each distance, d, and 10 cm at approximately 20 s intervals.
Animal experimental procedure
Animal preparation
The animal experiments described were carried out under an approved protocol from our Institution's animal ethics committee. The animal preparation closely follows preparation used in previous fMRI CBV experiments using MION (Mandeville et al., 1998) . The CO 2 responsivity experiment requires full breathing control by a ventilator, necessitating a tracheostomy and use of a paralytic to avoid the animal breathing around the ventilator. Three Sprague-Dawley rats (weight 280 AE 10 g) were anesthetized with 3% isoflurane in oxygen for surgery. A tracheostomy was performed and femoral and venous cannulas were inserted. After surgery, the rats were temporarily mechanically ventilated with a mixture of 1-1.5% isoflurane in an air-oxygen mixture. After initiation of mechanical ventilation, rats were paralyzed with a 2 mg/kg bolus of pancuronium followed by continuous IV infusion at 2 mg/kg/h. Before beginning MPI experiments, isoflurane was discontinued and anesthesia was maintained with a 50 mg/kg IV bolus of α-chloralose, followed by continuous infusion of 25 mg/kg/h. The rats were positioned on top of a heating blanket on a custom plastic bed with their front incisors inserted in an adjustable bar. The heating blanket circulated water at 40 C to maintain body temperature. The single-sided detector was positioned tightly above the rats' heads as shown in the schematic in Fig. 1 . The SPIO agent used was a 25 nm core Iron Oxide Nanoparticle with a PEG Carboxyl coating from Ocean Nanotech (San Diego, CA, USA) (same as phantom experiment). The blood half-life was measured to be approximately 1 h in rats. The agent was diluted to 0.5 mg Fe/ml and administered as four 1.4 ml infusions at a rate of 14 ml/h (7 mg Fe/hr). But the total dose administered was estimated to be approximately 8.5 mg Fe/kg after correction for the dead-space in the catheter which contained dose which did not reach the animal. This dose is comparable to the typical 8-10 mg Fe/kg SPIO dose used in fMRI studies in macaques (Leite et al., 2002) , and the 7 mg Fe/kg dose that has been used in humans (Qiu et al., 2012; Christen et al., 2013) . 
CO 2 responsivity
Ventilation parameters were adjusted to cycle between hypocapnia and hypercapnia in 5 min intervals. Hypocapnia was induced with hyperventilation of normal air by raising the respiration rate to 55 breaths per minute (BPM). Hypercapnia was induced with ventilation of a 5% CO 2 air mixture at a mildly depressed respiration rate of 32 BPM. Baseline respiration rate was 34 BPM. Arterial blood samples were acquired during each state for blood gas analysis.
Continuous time-series MPI data as described above were acquired during SPIO infusion and for 4 or more cycles of hypo/hypercapnia. Data were processed with either a 0.1 Hz digital low-pass filter or no filter. For time-courses acquired after SPIO infusion, a 2nd order trend was removed from the data to account for drift and SPIO clearance.
Results
The single-sided MPI detector system enabled direct time-series measurements of SPIO solutions in phantoms and in vivo. The system was first validated with phantom experiments to determine sensitivity limits as a function of distance from the detector and SPIO concentration. Fig. 4 shows voltage measurements over 13 time periods of~20s each for the three tested SPIO concentrations at 7 distances from the detector. Assuming a 5% blood concentration, we estimate that a 3 mm voxel in the brain contains 1.35 μL of blood. For a 10 mg Fe/kg SPIO dose in a 300 g rat with 64 ml/kg of total blood volume, a voxel with 5% CBV contains 211 ng Fe. Therefore, to detect a 25% neuroactivation-induced CBV change in this voxel, the detector must be sensitive to 53 ng Fe. Our results show that we can detect a 45 ng Fe sample at the surface of the detector with an SNR of about 5.4, indicating the ability to detect this 25% hemodynamic change at the surface of the detector without averaging. The signal level for the 3 samples scales roughly linearly with the Fe concentration in the sample, validating the ability to make quantitative measurements with MPI detector.
Figs. 5-7 show in vivo MPI data from the single-sided detector positioned closely over the anesthetized rat's head. Fig. 5a shows the raw time-series data during the four SPIO infusions in rat #1. All four 1.4 mg Fe infusions were administered at the same rate (7 mg Fe/hr). The approximately linear increase of SPIO in the blood during the infusion is represented by a proportional increase in the detected MPI signal. This validates the ability of the detector to measure Fe blood concentration in the sensitive region of the detector. Fitting the small clearance-only timeperiods between the injections in Fig. 5a with a 1st order clearance function suggests a clearance rate of 0.8 mg Fe/hr. Notably, the raw data in Fig. 5a exhibits an increase in noise as the signal level increases. As this is not the case in the phantom data (Fig. 4) , we infer that noise in the animal experiment is dominated by "physiological noise" at high signal levels. Fig. 5b presents a deeper look into the noise behavior in three animal experiments. The scatter plot shows the changing noise level as a function of MPI signal magnitude during the SPIO infusions. To calculate the noise data points, the raw data was first high-pass filtered (cut-off at 0.2 Hz) to isolate the noise. Then, the plotted noise data points were calculated at each time point as the standard deviation of the previous 40 data points. A linear fit (dashed line) shows that the noise increases at a rate of 9.1 mV noise/1 V MPI signal. There is a baseline noise level of~60 nV (solid line) below which thermal noise dominates and the noise level is independent of the signal level. The cross-over from thermal noise dominance to physiological noise dominance occurs at a signal level of~3.2 μV in our experiments. For MPI signal levels above this baseline, the observed noise was proportional to the signal. Fig. 6 shows four cycles of the CO 2 responsivity experiment for rat #1. In this dataset a 1st order linear trend was removed (to remove baseline drift from SPIO clearance) and the data was low-pass filtered with a Fig. 7 shows MPI CO 2 responsivity data for the three rats. The unfiltered MPI signal is plotted as a percent signal change for four cycles of hyper/hypocapnia for each animal, as well as the average of the four cycles. The average percent signal modulation in these three experiments was 9.6 AE 0.8%. The absolute signal level and noise level varied in the 3 experiments because of variations in the drive field amplitude, the remaining concentration of the SPIO in the blood at the time of the experiment, induced ΔpaCO 2 , and detector positioning. The rat #1 experiment was performed with a drive field of 13 mT at the surface at the detector approximately 70 min post-infusion. The rat #2 experiment was performed with a drive field of 11 mT approximately 70 min postinfusion. The rat #3 experiment was performed with a drive field of 14 mT approximately 160 min post-infusion.
Discussion
The magnetic particle detector developed for measuring brain hemodynamic time-series yielded successful proof-of-concept results. Phantom experiments validated detection sensitivity to physiologically relevant SPIO concentrations and demonstrated the spatially limited sensitivity profile of the detector. In vivo rodent studies confirmed high sensitivity to CBV changes and also revealed a dominant noise component that was signal-level dependent.
Although high CNR CO 2 responsivity was measured with the singlesided detector, the percent signal change seen (~10%) was smaller than a previous MRI experiment with up to 55% signal change (Mandeville et al., 1998) . One contributing factor is discrepancies in the amplitude of the CO 2 blood gas modulation (ΔpaCO 2 ), which may differ based on ventilation settings and the time period of hypercapnia intervals. We observed an induced ΔpaCO 2 ¼ 21 mmHg in rat #1, while Mandeville et al. induced a ΔpaCO 2 ¼ 30 mmHg, which is expected to lead to a greater CBV change. The sensitivity profile of the detector is also a contributing factor to the expected percent signal change. The most sensitive region of the detector was positioned on scalp over the sagittal sinus of the rat (Fig. 3) , which might have contributed a high baseline signal component that is minimally modulated by hypercapnia compared to the brain. This effect could easily be excluded with an MPI imaging device, where specific ROIs could be analyzed within the brain. Additionally, the observed smaller CBV modulation might arise from incomplete manipulation of the applied gasses through the animal "breathing around" the respirator.
The noise characteristics of the MPI time-series suggest a potential limiting factor to CNR. The noise in MPI measurements is typically considered to arise from the losses in the receiver coil and preamplifier (there is little "body loss noise" at the 75 kHz detection frequency (Myers et al., 2007) ). For these thermal sources, the noise power level is proportional to the total resistive loss which is independent of the signal strength. Thus, time-series variance from thermal noise sources (σ thermal 2 ) conventionally seen in MRI and MPI are constant. However, fMRI time-series are well known to be dominated by "physiological noise" (σ phys 2 ), which is perhaps more correctly described as "signal clutter" rather than true noise. It arises from variance from uncontrolled modulations of the signal by poorly described physiological factors and intrinsic fluctuations in brain activity. Therefore, it looks like "noise" but is actually a complicated physiological modulation of the signal amplitude that contains a neural contribution. Since it is a modulation of the signal, this noise source, σ phys , is routinely seen to vary in proportion to the signal level and in fMRI, its relative dominance can be controlled by the imaging parameters (Krüger and Glover, 2001; Triantafyllou et al., 2005) . Importantly, much of this variance derives from hemodynamic fluctuations, the spatial correlations of which have been shown to identify "functional connectivity" within the brain (Biswal et al., 1995; Raichle et al., 2001) . Thus, physiological noise in a detected time-series can have positive as well as negative attributes. While the observation of a physiological noise component in the MPI time-course motivates further investigation, it by no means demonstrates the feasibility of resting-state functional connectivity experiments. Resting state connectivity would require that the observed physiological noise contains a sizable hemodynamic component of neuronal metabolic origin. However other, less interesting, sources such as respiration and cardiac pulsations can modulate the detected signal time-course to produce noise-like fluctuations which also increases in proportion to the signal level similar to the observed effect. A considerable portion of the high CNR observed in the hypercapnia experiments can be attributed to the large sensitive region of our coillocalized detection circuit, with a sensitive volume equivalent to ã 6.5 mm cube. In contrast fMRI studies in rodents would typically have a spatial resolution below 1 mm; a sensitive volume about 275 fold smaller. However, the dominance of physiological noise in fMRI experiments (and possibly in fMPI experiments) complicates the comparison of acquisitions at different voxel volumes. The CNR of a fMRI acquisition is determined Fig. 7 . Data from the hypo/hypercapnia experiment (Fig. 6 ) repeated in 3 animals with different drive field amplitudes (13 mT for rat 1, 11 mT for rat 2, and 14 mT for rat 3). Four raw data cycles are overlaid as well as the mean data for each animal. The Fe concentration in the blood varies for each animal based on the timing of the experiment post-infusion (~70 min for rat 1,~70 min for rat 2,~160 min for rat 3). The absolute signal level and noise varies for the different experiments based on the drive field amplitude, SPIO concentration in the blood, detector positioning, and ΔpaCO 2 . However, a percent signal change of 8-10% was observed in all experiments.
by the temporal Signal to Noise Ratio (tSNR) of the time series. For many acquisitions, the time-series is physiological noise dominated and increasing signal levels by using coarser image resolution does not translate to significant improvement in tSNR (and thus functional CNR). For example increasing the voxel volume of a human 7T, 32 ch fMRI study from 1 Â 1x3 mm 3 to 5 Â 5x3 mm 3 (25 fold volume increase) yielded a tSNR increase of only about a factor of 1.8 (Triantafyllou et al., 2011) . In Kruger's original study (Krüger and Glover, 2001) , he determines that the asymptotic limit for grey matter tSNR is about 83, suggesting that increasing the voxel volume to very large detected regions will not improve the tSNR beyond this value. For a hypercapnia signal modulation of 20%, this yields a maximum "large voxel" CNR of about 17 for human MRI. To correctly estimate the relative sensitivity of the two modalities will require a full characterization of the fMPI physiological noise, followed by validation with similar resolution acquisitions.
One of the most promising opportunities for improvement in MPIbased hemodynamic measurements is development of better SPIO agent. Larger core SPIO nanoparticles contribute to higher MPI signal amplitude and could lead to improvements in image resolution due to a steep/high saturation level of the magnetization curve. However, relaxation effects counteract these potential improvements in large particles (Ferguson et al., 2009 ). In addition, our functional neuroimaging application requires a blood-pool agent with a long blood half-life, and larger particles tend to be cleared faster. Optimized nanoparticles for MPI, which are not currently commercially available, potentially could yield significant improvements in MPI imaging characteristics.
The MPI signal can also be modulated by the coil-body distance of either the drive or receiver coil. If these distances systematically change in a manner correlated to the induction of hypercapnia, some or all of the signal change attributed to hypercapnia might be spurious. We do not have any specific measurements on this possible effect, but note that the problem is similar to that faced in MRI hypercapnia measurement's where a local transmit and receiver coil is similarly fixed above the rodent's head.
Although a CBV change directly alters the particle concentration and thus detected MPI signal level, particle relaxation effects can also modulate the signal. The response of the particles to the applied field is modulated by magnetic relaxation effects. If the reorientation of the particle magnetization arises from the physical rotation of the particle (Brownian relaxation), the process is expected to be sensitive to both the temperature and viscosity of the surrounding environment. In contrast, if the reorientation of the particle magnetization occurs due to internal realignment without rotation (Neel relaxation), the effect is mainly dependent on temperature. In both cases, the sluggishness of the magnetization response can decrease sensitivity (Weaver et al., 2013) . For example, in the presence of a very long re-orientation time constant no MPI response is seen at all. The relaxation effects also adversely affect image resolution. Thus, signal changes resulting from task-correlated modulations of temperature or viscosity could mimic hemodynamic changes, and relaxation effects can negatively impact MPI sensitivity and spatial resolution.
Relaxation times increase as a function of the particle size for both mechanisms and for the Brownian mechanism, the hydrodynamic diameter of the particle is important. The MPI sensitivity and spatial resolution for particles with core sizes in the 18-32 nm range (a typical range for MPI detection, including our 25 nm core) were experimentally determined by Tay et al. (2017) . They showed that the spatial PSF for 24.4 nm core particles (41 nm hydrodynamic core) was approximately twice that expected without relaxation and even greater blurring occurred for larger particles. Even so, the 24.4 nm particle provided the best combination of detectability and PSF of the particles detected.
Our study did not localize the MPI signal beyond the detector sensitivity region of the Faraday detectors, and a full tomographic study is needed to assess the hemodynamic sensitivity as a function of detection volume (voxel volume) similar to those done for human MRI (Krüger and Glover, 2001) . A future extension of the presented MP detector to a tomographic imaging system will allow for fMPI mapping experiments in this rodent model, including somatosensory (forepaw or whisker) or visual stimulation and study of sensitivity as a function of voxel volume. Although forepaw stimulation was attempted with the presented detector, we believe that fCBV in the somatosensory cortex was obscured by the large baseline signal from non-activated brain regions as well as the scalp and sagittal sinus (as described above). Thus, the ability to create a full map or at least localize somatosensory cortex using a selection field will be required to perform fMPI activation studies of focally responding brain regions. In addition to focal fMPI experiments, pharmacological experiments (Liu et al., 2007) , which restrict averaging and thus place a premium on intrinsic CNR, might potentially benefit from MPI.
Functional imaging with MPI faces several barriers and downsides compared to other modalities. Firstly, it requires the injection of an agent, which will limit its use in many experiments and introduces regulatory barriers. There are currently only a few iron oxide nanoparticle agents approved for human use. Secondly, the availability of tomographic MPI scanners, while reported by multiple groups, and now commercially available for rodents, are not as widely available or as flexible in their ability to trade-off sensitivity, imaging speed and spatial resolution as current MRI scanners and, of course, a human MPI scanner has yet to be demonstrated so sensitivity and resolution estimates for human fMPI are even further from validation.
Conclusion
We present a single-sided Magnetic Particle detector used for fCBV measurement in rats. Experiments with the detector yielded dynamic measurements of brain hemodynamics using the principles of MPI. Even with the limited sensitivity volume of the single-sided detector, a robust 10% signal change was observed with a CNR of 50 during hyper/hypocapnia modulation. This serves as a proof-of-concept experiment that motivates the future design of full tomographic imaging systems dedicated to small animal functional neuroimaging with MPI.
